Time Trade-Off and Ranking Exercises Are Sensitive to Different Dimensions of EQ-5D Health States  by Rand-Hendriksen, Kim & Augestad, Liv Ariane
11
P
h
V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 7 7 7 – 7 8 2
Avai lable onl ine at www.sc iencedirect .com
journal homepage: www.elsevier .com/ locate / jva lTime Trade-Off and Ranking Exercises Are Sensitive to Different
Dimensions of EQ-5D Health States
Kim Rand-Hendriksen, Cand.Psychol, MSc1,2,*, Liv Ariane Augestad, MD1,2
1Department of Health Management and Health Economics, University of Oslo, Oslo, Norway; 2Health Services Research Centre, Akershus University Hospital,
Lørenskog, NorwayA B S T R A C TBackground: One method suggested for creating preference-based
tariffs for the new five-level EuroQol five-dimensional (EQ-5D) ques-
tionnaire is combining time trade-off (TTO) and discrete choice exer-
cises. Rank values fromprevious valuation studies can be used as prox-
ies for discrete choice exercises. This study examined rank and TTO
data to determine whether the methods differ in sensitivity to the
EQ-5D questionnaire dimensions. Methods: We used rank and TTO
data for 42 EQ-5D questionnaire health states from the US and UK
three-level EQ-5D questionnaire valuation studies, extracting overall
ranks of mean TTO and mean rank values, ranging from 1 (best) to 42
(worst). We identified pairs of health states with reversed overall ranks
between TTO and rank data and regressed overall rank differences
(TTO – ranking) on dummy variables representing impairments on
EQ-5D questionnaire dimensions.Results: Forty-three (US) and 41 (UK)
of H
al So
ttp://dx.doi.org/10.1016/j.jval.2012.04.002health state pairs displayed reversed rank order. Both US and UK re-
gression models on rank differences indicated that respondents rated
impairments involving pain/discomfort and anxiety/depression as rel-
atively worse in TTO than in the ranking task. Discussion: Different
dimension sensitivity between TTO and ranking methods suggests
that combining them could lead to inconsistent tariffs. Differences
could be caused by respondents focusing on the first presented dimen-
sions when ranking states or could be related to the longest endurable
time for health states involving pain/discomfort or anxiety/depression.
The observed differences call into question which method best repre-
sents the preferences of the population.
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Copyright © 2012, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Background
The EuroQol five-dimensional (EQ-5D) questionnaire is a health-re-
lated quality-of-life instrument that is used extensively to estimate
quality-adjusted life-years in health economic evaluations [1,2]. It
uses five dimensions of health: mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression. Up until recently, these di-
mensions could be rated at three levels, corresponding to “no prob-
lems,” “some problems,” and “extreme problems.” The EuroQol
group, however, has released official versions of the new five-level
EQ-5Dquestionnaire, anexpansionof theprevious three-level EQ-5D
questionnaire, in which each of the instrument’s five dimensions
can be rated at five levels. This expansion has increased the number
of combination health states from 243 to 3125.
Value sets for the three-level EQ-5D (EQ-5D-3L) questionnaire
have typically beenmade by usingmean preference values from the
general population, elicited by using the time trade-off (TTO)
method, in which health states are valued in relation to perfect
health anddeath. AsTTO interviews are costly and time-consuming,
EQ-5D-3Lquestionnaire valuation studieshave typically elicitedTTO
values for subsets (17–46) of the 243 possible health states, and val-
ues for all 243 states have been estimated by using regression mod-
eling. Differences in thenumber of health states directly valuedhave
been determined to contribute to observed differences between na-
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089 Blindern, 0318 Oslo, Norway.
E-mail: kim.rand-hendriksen@medisin.uio.no.
098-3015/$36.00 – see front matter Copyright © 2012, Internation
ublished by Elsevier Inc.tional EQ-5D questionnaire value sets [3], and two recent valuation
studies directly valuing greater numbers of health states have re-
vealed more complex interactions than those identified by previous
valuation studies [4,5]. The increase in the number of possible health
states that accompany the new five-level EQ-5D questionnaire
makes the conventional method economically unfeasible and has
led to a renewed focus on alternative valuation methods. One sug-
gested method for creating value sets for the five-level EQ-5D ques-
tionnaire is combining TTO values for a limited set of health states
with discrete choice exercise (DCE) data for a larger sample of health
states [6]. In DCE, respondents are asked to state which of two alter-
native health states they think is best, a simpler and less costly
method than TTO valuation. Combining TTO and DCE data in this
manner requires that the twomethodsmeasure the same construct
in similar manners. Preliminary analyses of results from a set of ex-
perimental valuation exercises performed in Norway, however, led
us towonderwhether ranking andTTOexercisesmaymake respon-
dents sensitive to different EQ-5D questionnaire dimensions; we ob-
served unexpected and stable mean rank transpositions between
TTO and ranking of health state pairs involving impairments on dif-
ferent EQ-5Dquestionnaire dimensions. Both in our valuation exper-
imentsand inpreviousTTO-basedEQ-5D-3Lquestionnairevaluation
studies, respondents have been familiarized with health state valu-
ation before TTO elicitation by having them rank the presented
ealth Management and Health Economics, University of Oslo, Pb.
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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states on a visual analogue scale (VAS). Lacking a gold standard for
comparison, several researchershaveproposed theuse of ranking as
a benchmark for comparison when considering the validity of other
valuation methods such as TTO [7,8]. Furthermore, the ranking task
can be considered as an ordered set of discrete choices. As such,
existing rank data may be used as imperfect proxies for DCE data.
Since ranking tasks were used in previous TTO-based EQ-5D ques-
tionnaire valuation studies, an abundance of data is available that
enables comparison of ranking and TTO values.
The aim of this study was to examine data from previous valuation
studies to determine whether respondents were sensitive to different di-
mensions of health state impairment when performing ranking of health
states to when performing TTO valuation.
Methods
Data
We used data from the UK (measuring and valuing health) [9] and
US [10] TTO-based EQ-5D questionnaire valuation studies, both of
hich asked respondents from the general population to value the
ame 42 EQ-5D questionnaire health states by using a ranking
ask, VAS, andTTO. Performed in 1993, theUK valuation studywas
he first large-scale national EQ-5D questionnaire valuation study
sing TTO interviews, and it has become the model upon which
ost subsequent valuation studies have been built. After exclu-
ions, 2997 respondents were included in the valuation sample.
he US valuation study was performed in 2001 by using an inter-
iew protocol that was nearly identical to the UK protocol. The
ampling techniques used were more advanced than in the UK
tudy, as were the statistical methods used to ensure population
epresentativeness. With 3773 respondents after exclusions, the
S valuation study has partially supplanted the UK study as the
aluation study of reference.
We were interested in two variables from these studies: rank
rder and TTO values for the measured EQ-5D questionnaire
ealth states.
Rank order
In both studies, respondents were familiarized with the EQ-5D
questionnaire and valuation of hypothetical health states prior to
TTOvaluation. First, theywere asked to describe their own current
health by using the EQ-5D questionnaire descriptive system. They
were then asked to rank from subjective best to worst a set of 15
cards, each describing a health state. The cards included the states
“death,” “unconscious,” EQ-5D questionnaire state 11111 (no
health problems), and 12 other EQ-5D questionnaire states se-
lected from the pool of 42 EQ-5D questionnaire states that were
valued in the study.Wewere interested in the rank order of the 12
health states from the pool of 42, and therefore discarded the
ranks of “death,” “unconscious,” and state 11111. The remaining
12 states then had ranks from 1 (best) to 12 (worst). We extracted
the mean rank values of all 42 measured EQ-5D questionnaire
health states from the UK and US data sets.
TTO values
The states “death” and 11111 were used as anchors in the TTO
interview, with values of 0 and 1, respectively. In the TTO inter-
view, respondents valued the 12 EQ-5D questionnaire health
states they had previously ranked, one by one in random order.
The objective of the TTO task was to identify the respondent’s
point of preferential indifference between 10 years in the impaired
health state in question (the target state) and a shorter life in state
11111. The point of indifferencewas identified through a sequence
of choice tasks in which the length of life in state 11111 was ma-nipulated. When equilibriumwas found, the TTO value of the tar-
get state was calculated as time in the target state divided by time
in perfect health (10 years). We extracted themean TTO values for
each of the 42 measured health states from the UK and US data
sets.
In the calculation of mean rank and TTO values, we used the
same methods and exclusion criteria employed in the respective
valuation studies. There were two primary differences between
the UK and US valuation studies that merit mention here: The US
valuation study intentionally oversampled certain ethnic groups.
To achieve population representativeness, respondent survey
weights were used. The other difference pertains to health states
considered worse than death. In both studies, TTO values elicited
when respondents considered the presented health states to be
worse than death were transformed before health state means
were calculated. However, the UK valuation study was performed
by using a transformation suggested by Patrick et al. [9,11], while
the US study was performed by using a method suggested by Tor-
rance [10,12]. Theworse-than-death valuation procedure and sub-
sequent transformations have been extensively discussed and
criticized for being atheoretical [3,13–16], and the differences be-
tween the two methods used have been found to contribute sub-
stantially to observed differences between the published US and
UK EQ-5D questionnaire tariffs [16]. Nevertheless, worse-than-
death transformation has been considered a necessary evil and
has been used in the calculation of all publishedmean-based TTO
tariffs for the EQ-5D questionnaire, with the Torrance transforma-
tion used only in the US valuation study and the Patrick transfor-
mation used in the remaining 14 valuation studies (UK, Spain,
Germany, Japan, Denmark, Zimbabwe, Netherlands, Argentine,
South Korea, Thailand, Poland, France, Chile, and Australia). We
consider discussion of the appropriateness of the valuation
studies’ exclusion criteria, sampling methods, and worse-than-
death transformation methods to be outside the scope of this
article. Because of previous observations of the substantial im-
pact that the choice of the transformation method makes, how-
ever, we performed sensitivity analyses substituting transfor-
mation methods.
Overall rank orders
Mean TTO values andmean rank orders are not directly compara-
ble. To enable a crude comparison using a common scale, we
chose to perform analyses on the overall rank orders of the mean
TTO values and the mean rank values: In each data set, the best
mean TTO value was assigned an overall rank value of 1 and the
worst was assigned a rank value of 42. Similarly, the state with the
best mean rank order (close to 1) was assigned an overall mean
rank value of 1 and the worst (close to 12) was assigned a value of
42. In this procedure, we disregard the relative distances between
mean TTO values and betweenmean ranks. For simplicity, wewill
refer to the overall mean TTO rank orders as mean TTO ranks and
the overall mean ranking task rank orders as mean rankings.
For each of the two data sets, we then subtracted the mean
rankings from themean TTO ranks, rendering ameasure of differ-
ence between the two valuation methods’ relative ordering of the
42 EQ-5D questionnaire health states. We refer to these values as
mean rank differences. A positive mean rank difference reflected
states that were ranked as worse in the TTO valuation than in the
ranking task, and a negativemean rank difference reflected states
ranked as worse in the ranking task than in the TTO.
Analyses
First, we analyzed the mean TTO ranks and the mean rankings to
identify pairs of health states for which the rank orders were re-
versed between mean TTO rank and mean rankings, that is, in
which one of the health stateswas considered to be better than the
779V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 7 7 7 – 7 8 2other using TTO and the other was considered better based on
rank order data.
Second, we used multiple linear regressions to determine
whether specific EQ-5D questionnaire dimension impairments
were related to the mean rank differences. For this purpose, we
used 10 dummy variables commonly used in valuation studies
(m2, m3, s2, s3, u2, u3, p2, p3, a2, and a3) to represent each of the
five EQ-5D questionnaire dimensions at “some problems” and “ex-
treme problems.” For example,m2 represents themobility dimen-
sion at “some problems” and p3 represents the pain/discomfort
dimension at “extreme problems.” Separately for the US and UK
data sets, we used the 42 mean rank differences as our dependent
variables and the 10 dimension dummy variables for the corre-
sponding health states as our independent variables. Using this
regression procedure, a positive coefficient value for a specific
Table 1 – Mean TTO, mean rank, and mean rank difference
Health state US data
TTO Ranking
di
Mean Rank Mean Rank
11121 0.88 1 1.55 1
11211 0.87 3 1.76 3
21111 0.87 2 1.77 4
11112 0.83 5 1.73 2
12111 0.84 4 2.08 5
12211 0.79 6 3.64 9
12121 0.79 7 3.22 6
11122 0.76 8 3.29 7
22121 0.74 9 3.56 8
22112 0.7 10 4.52 13
21222 0.68 12 4.07 11
12222 0.66 13 3.73 10
22122 0.68 11 4.09 12
11312 0.65 14 4.97 16
21312 0.63 15 4.77 15
11113 0.56 17 4.56 14
22222 0.6 16 5.81 19
13212 0.51 18 6.03 20
12223 0.47 20 5.80 18
11131 0.39 23 5.59 17
13311 0.48 19 6.61 22
21232 0.41 21 6.33 21
21323 0.39 22 7.02 23
32211 0.33 26 7.36 28
23321 0.38 24 7.40 29
11133 0.29 28 7.13 24
22323 0.36 25 7.14 25
22331 0.3 27 7.22 27
21133 0.28 29 7.17 26
23232 0.22 31 8.18 31
33212 0.2 32 8.54 33
23313 0.22 30 8.36 32
22233 0.2 33 7.89 30
32223 0.2 34 8.54 34
13332 0.14 36 8.83 35
32232 0.15 35 8.86 36
33321 0.14 37 9.15 37
32313 0.13 38 9.25 38
32331 0.05 40 9.49 39
33232 0.06 39 9.86 40
33323 0.02 41 9.98 41
33333 0.1 42 11.20 42
EQ-5D, EuroQol five-dimensional; TTO, time trade-off.dummy variable would indicate that the health impairment rep-resented was related to worse rating using TTO than ranking,
while a negative coefficient would indicate that the impairment
was considered worse in the ranking.
Finally, as a measure of relative agreement between TTO and
rank values,we calculated Spearman’s Rho betweenUSmeanTTO
values and UK mean TTO values and between US mean rank val-
ues and UK mean rank values. These rank correlations were then
compared with Spearman’s Rho between mean TTO values and
mean rank values within the same data set.
Ethics, funding, and conflicts of interest
All analyses were performed on anonymized and publicly available
data from previously conducted studies. Therefore, no ethics commit-
r valued EQ-5D questionnaire health states.
UK data
k
nce
TTO Ranking Rank
difference
Mean Rank Mean Rank
0.85 3 1.66 2 1
0.87 2 1.64 1 1
0.88 1 1.82 4 3
0.83 5 1.68 3 2
0.83 4 1.86 5 1
0.76 6 3.02 7 1
0.74 7 3.19 8 1
0.73 8 3.00 6 2
0.64 10 3.87 9 1
0.66 9 3.87 10 1
0.56 11 4.26 11 0
0.54 13 4.43 12 1
0.53 14 4.58 13 1
0.55 12 4.63 14 2
0.52 15 5.13 17 2
0.39 17 4.64 15 2
0.50 16 5.10 16 0
0.38 18 5.60 19 1
0.21 20 6.07 20 0
0.21 21 5.40 18 3
0.33 19 6.24 21 2
0.06 25 6.49 22 3
0.15 22 6.91 24 2
0.15 23 7.04 25 2
0.13 24 7.34 27 3
0.05 29 6.87 23 6
0.05 26 7.78 29 3
0.02 27 7.39 28 1
0.07 30 7.24 26 4
0.09 32 8.06 30 2
0.02 28 8.08 31 3
0.07 31 8.22 32 1
0.15 34 8.34 33 1
0.18 36 8.70 37 1
0.23 37 8.61 34 3
0.23 38 8.63 36 2
0.13 33 8.98 39 6
0.15 35 8.62 35 0
0.27 39 8.98 38 1
0.33 40 9.62 40 0
0.38 41 9.83 41 0
0.54 42 11.12 42 0s fo
Ran
ffere
0
0
2
3
1
3
1
1
1
3
1
3
1
2
0
3
3
2
2
6
3
0
1
2
5
4
0
0
3
0
1
2
3
0
1
1
0
0
1
1
0
0tee has considered the appropriateness of our study.
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Results
Table 1 lists mean TTO ranks, mean rankings, and mean rank
differences from the US and UK data sets for the 42 measured
health states. Positive mean rank differences (i.e., the health
states that were ranked as worse on the TTO than in the ranking
Table 2 – Health state pairs with reversed mean rank orde
US data
EQ-5D
questionnaire
vector
Mean TTO
ranks
Mean
rankings
a b a b a b
11211 21111 3 2 3 4
11112 11211 5 3 2 3
11112 21111 5 2 2 4
11112 12111 5 4 2 5
12121 12211 7 6 6 9
11122 12211 8 6 7 9
22121 12211 9 6 8 9
12222 21222 13 12 10 11
12222 22112 13 10 10 13
12222 22122 13 11 10 12
21222 22112 12 10 11 13
21222 22122 12 11 11 12
22122 22112 11 10 12 13
21312 11312 15 14 15 16
11113 11312 17 14 14 16
11113 21312 17 15 14 15
11113 22222 17 16 14 19
12223 22222 20 16 18 19
11131 22222 23 16 17 19
12223 13212 20 18 18 20
11131 12223 23 20 17 18
11131 13212 23 18 17 20
12223 13311 20 19 18 22
11131 13311 23 19 17 22
11131 21232 23 21 17 21
21232 13311 21 19 21 22
11131 21323 23 22 17 23
11133 22323 28 25 24 25
22323 23321 25 24 25 29
11133 23321 28 24 24 29
11133 22331 28 27 24 27
11133 32211 28 26 24 28
22331 23321 27 24 27 29
32211 23321 26 24 28 29
21133 23321 29 24 26 29
22331 32211 27 26 27 28
21133 22331 29 27 26 27
21133 32211 29 26 26 28
22233 23232 33 31 30 31
22233 23313 33 30 30 32
23232 23313 31 30 31 32
13332 32232 36 35 35 36
32331 33232 40 39 39 40
EQ-5D, EuroQol five-dimensional; TTO, time trade-off.task) were common for health states dominated by impairmentsinvolving the pain/discomfort or anxiety/depression dimensions,
while negative mean rank differences were predominant for
health states with impairments involving mobility, self-care, and
usual activities. For instance, state 11131, indicating extremepain/
discomfort, had a US (UK)mean ranking of 17 (18) and amean TTO
rank of 23 (21), yielding a rank difference of 6 (3).
We identified a total of 43 US and 41 UK health state pairs for
which the mean TTO ranks and mean rankings were reversed.
These are listed in Table 2. Most of these transpositions took place
in health state pairs in which one state was dominated by impair-
ments of mobility, self-care, and usual activities (considered best
when performing TTO) while the other was dominated by impair-
ween TTO and ranking.
UK data
EQ-5D
questionnaire
vector
Mean TTO
ranks
Mean
rankings
a b a b a b
11112 21111 5 1 3 4
11121 21111 3 1 2 4
11211 21111 2 1 1 4
11112 12111 5 4 3 5
11122 12211 8 6 6 7
11122 12121 8 7 6 8
22121 22112 10 9 9 10
12222 11312 13 12 12 14
22122 11312 14 12 13 14
11113 22222 17 16 15 16
11113 21312 17 15 15 17
22222 21312 16 15 16 17
11131 13212 21 18 18 19
11131 12223 21 20 18 20
11131 13311 21 19 18 21
12223 13311 20 19 20 21
11133 21323 29 22 23 24
21232 21323 25 22 22 24
11133 32211 29 23 23 25
21232 32211 25 23 22 25
11133 23321 29 24 23 27
21133 23321 30 24 26 27
21232 23321 25 24 22 27
11133 22331 29 27 23 28
21133 22331 30 27 26 28
11133 22323 29 26 23 29
21133 22323 30 26 26 29
22331 22323 27 26 28 29
11133 33212 29 28 23 31
21133 33212 30 28 26 31
23232 33212 32 28 30 31
23232 23313 32 31 30 32
13332 32313 37 35 34 35
13332 32223 37 36 34 37
32232 32223 38 36 36 37
13332 33321 37 33 34 39
22233 33321 34 33 33 39
32223 33321 36 33 37 39
32232 33321 38 33 36 39
32313 33321 35 33 35 39
32331 33321 39 33 38 39r betments involving pain/discomfort and anxiety/depression (consid-
t
t
s
i
s
w
m
t
e
v
h
h
781V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 7 7 7 – 7 8 2ered best when ranking). For instance, in both data sets, state
13311, indicating extreme problems in the self-care and usual ac-
tivities dimensions, was considered better than state 11131 (pre-
sented previously) in TTO while it was considered worse in rank-
ing.
Table 3 lists the regression models predicting rank differences
using the 10 main dimension dummies. The coefficients for the
dummy variables representing the first three dimensions (m2,m3,
s2, s3, u2, and u3) were consistently negative, while the coeffi-
cients for the dummies representing the final two dimensions (p2,
p3, a2, and a3) were consistently positive.
Spearman’s Rho values between US and UKmean values were
0.991 (TTO, P  0.001) and 0.990 (rank, P  0.001). Spearman’s Rho
values between mean TTO and mean rank values were 0.984 (US,
P  0.001) and 0.983 (UK, P  0.001).
Discussion
Respondents in the two valuation studies appear to have been
more sensitive to impairments on the dimensions of mobility,
self-care, and usual activities when ranking health states and
more sensitive to impairments involving pain/discomfort and
anxiety/depression in the TTO valuation. In both data sets, there
were many examples of health state pairs in which respondents
ranked one state as better than the other but were willing to trade
awaymore life time to avoid the health states of the better ranked
state than theworst. In nearly all these pairs, one of the states was
predominantly impaired on the first three dimensions of the
EQ-5D questionnaire, while the other state was dominated by im-
pairments on the last two dimensions. The regression models in-
dicate that the health state pairs in which the overall rank order
was reversed between ranking and TTO represent extreme exam-
ples of a general trend. This apparent inconsistency in how the
twomethods value the different dimensions of health constitutes
a breach of procedural invariance [17,18] and casts doubt on the
wo methods’ ability to capture the same underlying construct—
he population’s preferences for EQ-5D questionnaire health
tates. Because the analyses were performed on ranks of means,
nterpreting the magnitude of the observed differences is not a
traightforward task. Spearman’s Rho between US and UK data
ithin each method, however, was higher than between those
ethods for the same country, indicating that the difference be-
ween the methods is greater than the differences in mean pref-
rences between the two countries.
There is a large body of literature documenting how different
aluationmethods yield different results [7,19–21]. For instance, it
as often been found that the standard gamble method yields
Table 3 – Multiple linear regression models predicting mea
Predictor
Coef
Constant 0
m2 Mobility level 2 1
m3 Mobility level 3 0
s2 Self-care level 2 0
s3 Self-care level 3 1
u2 Usual activities level 2 0
u3 Usual activities level 3 1
p2 Pain/discomfort level 2 1
p3 Pain/discomfort level 3 2
a2 Anxiety/depression level 2 0
a3 Anxiety/depression level 3 1
Statistically significant (P  .05) coefficients in bold.igher values than TTO, which yields higher values than the VAS.Such comparisons, however, have typically focused on differences
in absolute levels of values or on the functional form of values
from different instruments. Our finding of dimension-specific in-
consistencies between the ranking and TTOmethods underscores
the importance of investigating potential disagreements on the
level of health dimensions when comparing valuation methods.
In addition to the analyses presented, we performed several
tests that did not add any new information: Analyses on data from
the Danish TTO-based valuation study replicated the findings
from the UK and US data. Switching the transformation methods
for health states considered worse than death in the TTO task
resulted in slight changes to the magnitudes of the regression
coefficients, but the overall picture remained unchanged. In the
two valuation studies fromwhich our data were acquired, respon-
dents were asked to value the same set of health states by using a
thermometer-like VAS. VAS valuation was performed right after
the ranking task, with the health states still in their ranked order,
meaning that the VAS values were highly dependent on the pre-
vious ranking. We performed analyses substituting the overall
mean rankings with overall rankings of mean VAS scores, with
nearly identical results. Because of the intertwined nature of the
ranking and VAS valuations, this does not necessarily mean that
VAS valuation without prior ranking would induce sensitivity to
the same EQ-5D questionnaire dimensions that ranking appar-
ently does. Details and results for these analyses are available
from the corresponding author.
This study had four primary limitations. First, because ranking
can be conceptualized as a set of discrete choices, we have used
rank order as a proxy for DCE data. Empirical testing however,
would be required to determine whether respondents perform
consecutive DCE tasks in the same manner as they perform rank-
ing. As ranking involves simultaneous comparison of more items
than does DCE, there may be differences in how the two tasks are
processed by respondents. Second, we analyzed the rank order of
mean values from TTO and mean rank data. This procedure is
insensitive to the relative distance between health states. Third,
the analyses were performed on data collected for the EQ-5D-3L
questionnaire. The degree to which this is generalizable to the
five-level version is unknown, though some studies have been
performed indicating that there is considerable agreement be-
tween the three- and five-level versions [22–25]. Finally, multiple
linear regressions on rank data are not ideal. Because our objective
was to identify and illustrate differences between the two valua-
tion methods in terms of how respondents value the five EQ-5D
questionnaire dimensions, we considered multiple linear regres-
sions to be the simplest andmost accessible method sufficient for
our purpose. This study does not inform us as to why respondents
nk differences.
ata (r2  .626) UK data (r2  .755)
t P Coefficient P
0.287 0.205 0.703
0.004 1.424 0.006
0.298 1.542 0.017
0.130 0.334 0.527
0.021 0.918 0.150
0.156 1.002 0.085
0.109 1.857 0.004
0.048 0.418 0.395
<0.001 3.250 <0.001
0.547 1.302 0.017
0.018 1.693 0.003n ra
US d
ficien
.683
.789
.765
.960
.796
.970
.167
.182
.609
.371
.547rank the EQ-5D questionnaire dimensions in an apparently incon-
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782 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 7 7 7 – 7 8 2sistent manner when performing ranking and TTO valuation. We
offer two hypotheses that are congruent with our findings but
must warn that they are speculative at present. First, the respon-
dents could bemore influenced by the ordering of presentation for
the EQ-5D questionnaire dimensions when ranking than when
performing TTO; the ordering was fixed in both studies, and it is
conceivable that respondents performing ranking of health states
start by comparing the first dimension, then go on to the second,
and so on, increasing the relative impact of impairments on the
first dimensions. Fortunately, if this is the case, the observed dif-
ferences should disappear if the ordering of the five dimensions
was randomized. Alternatively, it could be that time framing is
more salient in TTOand that respondents find the thought of long-
term impairments involving pain/discomfort or anxiety/depres-
sion unbearable. This interpretation is compatible with previous
findings about nonlinear time preferences and the concept of
maximum endurable time in TTO [26–29]. In a recent cognitive
debriefing study of EQ-5D questionnaire valuation by Bailey et al.
[30], respondents frequently ignored the 10-year duration in the
VAS and ranking tasks but were sensitive to time when perform-
ing TTO.
The observed inconsistency between TTO and ranking raises
two important issues: First, which of the two valuation methods
should be considered as being the best or most correct? Second, if
these findings can be generalized to TTO and DCE for the five-level
version of the EQ-5D questionnaire, combining the two methods
for the purpose of tariff generation may prove troublesome. If we
understand themethods required for suchhybrid tariff generation
correctly, and DCE behaves as ranking does in our study, combin-
ing data from a small set of health states valuedwith the TTOwith
data from a large set of states valued with DCE could result in
inconsistent tariffs: health states in proximity to the states se-
lected for TTO valuation would be more influenced by pain/dis-
comfort and anxiety/depression, while states further from the se-
lected TTO states would bemore influenced bymobility, self-care,
and usual activities. In conclusion, experimental studies on DCE
and TTO need to be performed to determine whether the two
methods can be combined for the purpose of tariff generation
without creating inconsistent tariffs.
Source of financial support: The study was indirectly financed
by the Norwegian Research Council and the Southern and Eastern
Regional Health Care Authorities through PhD grants for the first
two authors. Neither funding source had any involvement in the
study.
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